Test validity of periodic liver function tests in a population of Japanese male bank employees

Journal of Clinical Epidemiology

Volumn 54, Issue 9, 2001, Pages 945-951

  Yano, Eiji ^a   Tagawa, Kazumi ^b   Yamaoka, Kazue ^a   Mori, Masaki ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c Medical Center   (Japan)

Author keywords

Hepatic virus carrier; Liver function test; Periodic health examination; Screening test; Sensitivity; Specificity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; COST; FATTY LIVER; HEPATITIS; HUMAN; HUMAN EXPERIMENT; JAPAN; LIVER FUNCTION TEST; MALE; MEDICAL EXAMINATION; NORMAL HUMAN; OBESITY; OCCUPATIONAL SAFETY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ULTRASOUND; VIRUS CARRIER;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; JAPAN; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MASS SCREENING; MIDDLE AGED; OCCUPATIONAL HEALTH; SENSITIVITY AND SPECIFICITY;

EID: 0034889474     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00355-9     Document Type: Article

References (36)

1. Therapy of hepatitis C; overview
2. Natural history of hepatitis C
3. Syokugyo Syudan no Kan-Kenshin
4. Pathogenesis-screening tests for liver dysfunction in the asymptomatic patients and elevated alanine aminotransferase values an their diagnostic efficacies in primary care medicine
5. Early detection of hepatocellular carcinoma-high risk group and mass screening
6. The incidence of alcoholic liver disease in Japan (1976-1985)
7. The accuracy of ultrasound in the detection of fatty infiltration of the liver
8. Epidemiology of hepatitis C virus infection in Japan
9. Validation of screening procedures
10. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
11. Non-A, non-B post-transfusion hepatitis. Looking back in the second decade
12. Clinical outcomes after transfusion-associated hepatitis C
13. Hepatitis C in asymptomatic blood donors
14. Treatment of chronic type B and C hepatitis with interferon alpha; an economic appraisal
15. Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B antigen-positive chronic hepatitis B
16. Long-term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitis B
17. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
18. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
19. Prediction of risk of liver disease by alcohol intake, sex, and age; a prospective population study
20. Serum-gamma-glutamyl-transferase in screening and continuous control of heavy drinking in middle-aged men
21. Serum activity of gamma-glutamyl-transpeptidase (GGT) in relation to estimated alcohol consumption and questionnaires in alcohol dependence syndrome
22. Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in worker men
23. Drinkwatchers description of subjects and evaluation of laboratory markers of heavy drinking
24. Gamma-glutamyl-transpeptidase and mean corpuscular volume; their usefulness in the assessment of in-patient alcoholics
25. A community screening test for high alcohol consumption using biochemical and haematological measures
26. Utility and evaluation of biochemical markers of alcohol consumption
27. The natural history of nonalcoholic fatty liver; a follow-up study
28. Fatty liver disease in morbid obesity
29. Ultrasonic and laboratory studies on fatty liver in white-collar workers
30. A study on fatty liver in health examination participants